2 cryptocurrency Top Featured snippets

The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)Schlegel, Governor of the Swiss National Bank: Since the last interest rate decision, the inflation rate has been lower than expected. The development of the Swiss franc is still an important factor.On the 12th, the South Korean National Assembly voted to impeach the Minister of Justice Park Hyung-jae and the Director of the Police Department Zhao Zhihao.

Ali's Taotian Supply Chain Company increased its capital to 50 million yuan, an increase of 400%. Tianyancha App shows that recently, Hangzhou Taotian Supply Chain Co., Ltd. has undergone industrial and commercial changes, and its registered capital has increased from 10 million yuan to 50 million yuan, an increase of 400%. At the same time, some key personnel have changed. Hangzhou Taotian Supply Chain Co., Ltd. was established in January 2016, and its legal representative is Zhang Bowen. Its business scope includes supply chain management services, professional design services, socio-economic consulting services, primary processing of edible agricultural products, primary processing of non-edible agricultural products, wholesale of aquatic products, acquisition of aquatic products, frozen processing of aquatic products, etc. It is wholly owned by Alibaba (China) Network Technology Co., Ltd.Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.Italy's seasonally adjusted unemployment rate in the third quarter was 6.1%, and the previous value was 6.80%.

Lou Feipeng, a researcher at the Postal Savings Bank: The full implementation of the personal pension system is just the right time for financial institutions to usher in development opportunities. "The full implementation of the personal pension system is just the right time." Lou Feipeng, a researcher at China Postal Savings Bank, said that in the past two years, the personal pension system has achieved remarkable results in general, with a rapid increase in the number of accounts opened and a rapid enrichment of financial products. The data shows that at the end of June 2024, the number of individual pension accounts opened exceeded 60 million. "The implementation of the personal pension system in the pioneering urban areas has enabled the residents to have a more intuitive understanding of the personal pension system. At the same time, it has accumulated rich experience for government departments and financial departments to improve the personal pension system and optimize personal pension financial services. " Yan Feipeng said. (SSE)Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.Schlegel, Governor of the Swiss National Bank: It aims to stabilize the inflation rate at 0-2%. We can tolerate inflation temporarily below the target range of 0-2%.